References
1 Bata BM, Hodge DO, Mohney BG: Neurofibromatosis Type 1: a population-based population study. J Pediatric Ophthalmol Strabismus 2019;56:243-247
2 National Institute of Health Consensus Development Conference Statement. Neurofibromatosis. Bethesda, Md, USA, July, 1987. Neurofibromatosis 1988;1(3):172-178
3 Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O’Connell P, White R, Bader JL, Miller RW, Birnboim HC, Buchberg AM, Bedigian HG, Jenkins NA, Copeland NG, Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL, Cawthon RM, O’Connell P, Buchberg AM, et al: A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990;62:193–201.
4 De Castro IJ, Soares da Silva EB, dos santos TR et al: T-cell lymphoma in a patients with neurofibromatosis type 1 and AIDS. Case Rep Oncol 2017;10:161-168
5 Isa SF, Silas A, Daniyam C et al: An HIV-1 infected patient with neurofibromatosis type 1: a case report. The Nigerian Health Journal 2012;12:52-54
6 Hiesgen J, Variava E: Neuroendocrine tumult in a patients with neurofibromatosis type 1 and HIV. S Afr J HIV Med 2015;16(1), Art. #323, 4 pages
7 Forte D, Nabais A, Pontinha C et al: Simultaneous supratentorial and infratentorial pilocytic astrocytoma in an adult patients with concurrent neurofibromatosis type 1 and HIV infection. World Neurosurg 2018;117:172-177
8 Scoot PV, Dreesen JCFM, Cooen E et al: Preimplantation gets testing for more that one genetic conditions. Hum Reprod 2019;34:1146-1154 al 2019
9 Floridia M, Masuelli G, Meloni A, Cetin A, Tamburini E, Cavalieri AF, Danzero S et al; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy. BJOG 2017;124:1218-1223
10 Eppes C: Low risk of HIV transmission for women on combined antiretroviral therapy. BJOG 2017;124:1224
11 Gruber A, Pacault M. El Khatatri EP et al: Non-invasive prenatal diagnosis of paternally inherited disorders from maternal plasma: detection of NF1 and CTFR mutation using droplet digital PCR. Clin Chem Lab Med 2018;56:728-738
12 Farhi D, Bastuji-G arin S, Khosrotehrani K et al: Neurofibromatosis 1: analysis of the demand for prenatal diagnosis in a French cohort of 361 patients. Am J Med Genet A 2008;146(A):159-165
13 Terzi YK, Oguzkan-Balci S, Anlar B ET Al: Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling. Genet Couns. 2009;20:195-202.
14 Terry AR, Merker VL, Barker FG 2nd et al: Pregnancy complications in woman with rare tumor suppressor syndromes affecting central and peripheral nervous system. Am J Obstet Gynecol. 2015; 213(1) :108-9.
15 Leppävirta, J, Kallionpää, RA, Uusitalo, E, et al. The pregnancy in neurofibromatosis 1: A retrospective register‐based total population study. Am J Med Genet Part A . 2017; 173A: 2641 2648. https://doi.org/10.1002/ajmg.a.38372
16 Walther MM, Herring J, Enquist E et al: von Reckinghausen’s disease and pheochromocytomas. J Urol 1999;162:1582-1586
17 Leppävirta, Jussi et al. “Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study.” Orphanet journal of rare diseases vol. 13,1 5. 15 Jan. 2018, doi:10.1186/s13023-017-0756-4
18 Peters H, Francis K, Harding K, Tookey PA, Thorne C: Operative vaginal delivery and invasive procedures in pregnancy among women living with HIV. Eur J Obstet Gynecol Reprod Biol 2017;201:295-299
19 ThakKar SD, Feigen U, Mautner VF: Spinal tumours in neurofibromatosis type 1: an MRI study of frequency multiply and variety. Neuroradiology 1999;41:625-629
20 Spiegel JE, Hapgood A, Hess PE: Epidural anesthesia in a parturient with neurofibromatosis type 2. Int J Ostet Anesth 2005;14:336-339
21 Gaiser R: Low complication rate associated with cesarean section under spinal anesthesia for HIV- infected women on antiretroviral therapy. Survey of Anesthesiology 2003;47: 215
22 Benton S, Reese A: HIV and the obstetric patient: anesthetic considerations. The Internet Journal of Anes thesiology 2009; Volume 24 Number 1 pages 1-7
23 Grownwald C, Vowinkel T, Hahnenkamp K: Regional anesthetic procedures in immunosuppressed patients: risk of infection. Current Opinion Anesthesiology 2011;24:698-704
24 Korf BR: Malignancy in neurofibromatosis type 1. Oncologists 2000;5:477-485
25 Schmutz JL: Dermatologic disease influenced by pregnancy (French) Presse Med 2003;32:1809-1812
26 Nebesio TD, Ming W, Chen S et al: Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy. Glia 2007;55:527-5362007
27 Cesaretti C, Melloni G, Quagliarini D et al: Neurofibromatosis type 1 and pregnancy: maternal complications and attitudes about prenatal diagnosis. Am J Med Genet A 2013;161:386-388